| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697200 | Brachytherapy | 2017 | 6 Pages |
Abstract
In medically inoperable, clinical stage I endometrial cancer patients with multiple comorbidities, definitive triple-tandem, HDR brachytherapy results in mild acute toxicity. In addition, HDR brachytherapy achieves relatively lower doses to surrounding normal tissues as compared to SBRT.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Greg Kauffmann, Tianming Wu, Hania Al-Hallaq, Yasmin Hasan,